Outlook Therapeutics Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2015 - 2019
Revenue	1.51	-	-	-	-	-	Upgrade
Cost of Revenue	41.88	41.76	26.45	42.33	38.96	26.34	Upgrade
Gross Profit	-40.37	-41.76	-26.45	-42.33	-38.96	-26.34	Upgrade
Selling, General & Admin	39.97	29.94	26.67	20.74	12.77	9.97	Upgrade
Operating Expenses	32.25	29.94	26.67	20.74	12.77	9.97	Upgrade
Operating Income	-72.62	-71.7	-53.13	-63.07	-51.73	-36.31	Upgrade
Interest Expense	-0.69	-3.16	-2.53	-1.49	-0.94	-1.76	Upgrade
Interest & Investment Income	0.91	0.91	0.97	-	-	-	Upgrade
Earnings From Equity Investments	-0.12	-0.1	-0.01	-0.05	-0.05	-	Upgrade
Other Non Operating Income (Expenses)	35.33	1.15	0.05	0.47	-0.45	1.98	Upgrade
EBT Excluding Unusual Items	-37.19	-72.91	-54.65	-64.14	-53.16	-36.09	Upgrade
Asset Writedown	-	-	-	-	-	-0.53	Upgrade
Other Unusual Items	-6.25	-2.46	-4.33	-1.91	-	-1.9	Upgrade
Pretax Income	-43.44	-75.36	-58.98	-66.05	-53.16	-38.51	Upgrade
Income Tax Expense	0	0	0	0	0	-3.27	Upgrade
Earnings From Continuing Operations	-43.44	-75.37	-58.98	-66.05	-53.16	-35.24	Upgrade
Net Income	-43.44	-75.37	-58.98	-66.05	-53.16	-35.24	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	-	13.63	Upgrade
Net Income to Common	-43.44	-75.37	-58.98	-66.05	-53.16	-48.87	Upgrade
Shares Outstanding (Basic)	29	19	13	11	8	4	Upgrade
Shares Outstanding (Diluted)	29	19	13	11	8	4	Upgrade
Shares Change (YoY)	82.32%	48.29%	17.96%	38.91%	110.43%	298.84%	Upgrade
EPS (Basic)	-1.50	-4.06	-4.72	-6.23	-6.96	-13.47	Upgrade
EPS (Diluted)	-1.50	-4.06	-4.72	-6.23	-6.96	-13.47	Upgrade
Free Cash Flow	-56.43	-68.79	-42.97	-56.67	-54.25	-31.79	Upgrade
Free Cash Flow Per Share	-1.95	-3.71	-3.44	-5.34	-7.11	-8.76	Upgrade
Operating Margin	-4824.52%	-	-	-	-	-	Upgrade
Profit Margin	-2885.82%	-	-	-	-	-	Upgrade
Free Cash Flow Margin	-3748.97%	-	-	-	-	-	Upgrade
EBITDA	-72.51	-71.59	-53.08	-62.87	-51.46	-35.76	Upgrade
D&A For EBITDA	0.12	0.11	0.04	0.2	0.26	0.55	Upgrade
EBIT	-72.62	-71.7	-53.13	-63.07	-51.73	-36.31	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q